← Back to Search

Lidocaine + Ketamine for Postoperative Pain

Phase 3
Recruiting
Led By Steven Minear, MD
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first postoperative 48 hours (measured at the end of the pacu stay as well as on the 1st and 2nd postoperative mornings).
Awards & highlights

Study Summary

This trial will test if lidocaine and/or ketamine reduces pain and need for opioids after surgery.

Eligible Conditions
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first postoperative 48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and first postoperative 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain
Total opioid consumption
Secondary outcome measures
Overall benefit of analgesia score (OBAS)
Quality of recovery (QoR-15) score
Other outcome measures
Nausea or vomiting
Postoperative hospital length of stay
Time to first opioid administration

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Lidocaine and placeboExperimental Treatment1 Intervention
Lidocaine and placebo
Group II: Lidocaine and ketamineExperimental Treatment1 Intervention
Lidocaine and ketamine
Group III: Ketamine and placeboExperimental Treatment1 Intervention
Ketamine and placebo
Group IV: Placebo and placeboPlacebo Group1 Intervention
Placebo and placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ketamine
2011
Completed Phase 4
~1090
Lidocaine
2011
Completed Phase 4
~1360

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,026 Previous Clinical Trials
1,365,656 Total Patients Enrolled
9 Trials studying Postoperative Pain
2,655 Patients Enrolled for Postoperative Pain
Steven Minear, MDPrincipal InvestigatorCleveland Clinic Florida

Media Library

Lidocaine and ketamine Clinical Trial Eligibility Overview. Trial Name: NCT04084548 — Phase 3
Postoperative Pain Research Study Groups: Lidocaine and placebo, Lidocaine and ketamine, Placebo and placebo, Ketamine and placebo
Postoperative Pain Clinical Trial 2023: Lidocaine and ketamine Highlights & Side Effects. Trial Name: NCT04084548 — Phase 3
Lidocaine and ketamine 2023 Treatment Timeline for Medical Study. Trial Name: NCT04084548 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I possibly be included as a candidate in this research?

"The ideal candidate for this clinical trial would experience pain, postoperative pain, and be between 18-80 years old. Out of the 420 possible participants, the investigators are looking to enroll."

Answered by AI

What conditions are Lidocaine and ketamine used to treat?

"Lidocaine and ketamine is most often used to treat cervical syndrome. However, it has a variety of other potential applications, such as treating minor burns, general anesthesia, and transplantation."

Answered by AI

Has the FDA cleared Lidocaine and ketamine for use?

"Lidocaine and ketamine have both been studied extensively and have been proven safe in multiple clinical trials, so they receive a score of 3."

Answered by AI

Could you please tell me if young adults are able to participate in this research?

"In order to participate in this research, patients must be between 18 and 80 years old. Out of the 634 clinical trials conducted, 108 were for patients under 18 and 626 were for patients over 65."

Answered by AI

To date, how many patients have signed up for this experiment?

"Yes, this is an ongoing trial that is looking for 420 individuals from a single location. The study was first posted on October 15th, 2019 and was updated as recently as March 17th, 2022."

Answered by AI

Are Lidocaine and ketamine often studied together?

"There are 237 ongoing studies worldwide that are investigating the effects of Lidocaine and ketamine. 50 of these studies are in Phase 3. While Duarte, California has several ongoing clinical trials, there are a total of 1296 research facilities."

Answered by AI
Recent research and studies
~76 spots leftby Apr 2025